Back
Beam Therapeutics Vs. Day One Biopharmaceuticals Industry Stock Comparison
Buy
69
BEAM
Beam Therapeutics
Last Price:
24.36
Seasonality Move:
70.47%
Buy
56
DAWN
Day One Biopharmaceuticals
Last Price:
15.11
Seasonality Move:
1.4%
Buy
69
Beam Therapeutics (BEAM)
is a Buy
Is Beam Therapeutics a Buy, Sell or Hold?
- The current Beam Therapeutics [BEAM] share price is $26.69. The Score for BEAM is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- BEAM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Day One Biopharmaceuticals (DAWN)
is a Buy
Is Day One Biopharmaceuticals a Buy, Sell or Hold?
- The current Day One Biopharmaceuticals [DAWN] share price is $15.01. The Score for DAWN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DAWN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BEAM Stock Price Chart
What is Beam Therapeutics's stock price today?
-
The Beam Therapeutics share price today is $26.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEAM is experiencing slight buying pressure.
DAWN Stock Price Chart
What is Day One Biopharmaceuticals's stock price today?
-
The Day One Biopharmaceuticals share price today is $15.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAWN is experiencing slight selling pressure.
BEAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 62.3 | Buy |
| Chaikin Money Flow: | 184423 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.57 - 25.91) | Buy |
| Bollinger Bands (100): | (23.08 - 27.42) | Buy |
DAWN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 60.85 | Buy |
| Chaikin Money Flow: | -528925 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.67 - 14.45) | Buy |
| Bollinger Bands (100): | (13.17 - 14.79) | Buy |
BEAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.68 | Buy |
| 20-day SMA: | 24.56 | Buy |
| 50-day SMA: | 24.8 | Buy |
| 200-day SMA: | 26.96 | Sell |
| 8-day EMA: | 25.24 | Buy |
| 20-day EMA: | 24.77 | Buy |
| 50-day EMA: | 25 | Buy |
| 200-day EMA: | 26.51 | Buy |
DAWN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.11 | Buy |
| 20-day SMA: | 14.13 | Buy |
| 50-day SMA: | 13.96 | Buy |
| 200-day SMA: | 14.58 | Buy |
| 8-day EMA: | 14.33 | Buy |
| 20-day EMA: | 14.13 | Buy |
| 50-day EMA: | 14.11 | Buy |
| 200-day EMA: | 14.28 | Buy |
Beam Therapeutics Earnings Growth & BEAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $0.07 per share.
Day One Biopharmaceuticals Earnings Growth & DAWN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and a decrease next year of $0.40 per share.
Beam Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Day One Biopharmaceuticals Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||